Search results

Filter

Filetype

Your search for "*" yielded 533480 hits

WCMM LU Welcomes new Co-director Professor Jonas Larsson from January 2020!

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 18 February 2020 Co-director Professor Jonas Larsson From January 2020 we warmly welcome professor Jonas Larsson as new Co-director! Jonas Larsson is Professor in Hematology and also bring long-term experience to WCMM LU as Director for StemTherapy – a National Initiative on Stem Cells for Regenerative Therapy. P

https://www.wcmm.lu.se/article/wcmm-lu-welcomes-new-co-director-professor-jonas-larsson-january-2020 - 2025-03-09

Celebration of the second round of WCMM LU Mentor program February 11 2020!

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 17 February 2020 At WCMM LU we believe in educating and supporting our PIs in professional development and academic leadership. All recruited PIs are welcomed to a mentor program, where they are matched with a mentor (a senior Professor at ot faculty) and invited to professional lead seminars in collaboration wit

https://www.wcmm.lu.se/article/celebration-second-round-wcmm-lu-mentor-program-february-11-2020 - 2025-03-09

Successful translational research between two researchers at WCMM Lund

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 2 July 2021 Excellent example on successful Translational Research at WCMM Lund between Anja Meissner and Martin Magnusson: - Phospholipid S1P suggested as a potential biomarker in cardiovascular disease Anja Meissner Martin Magnusson In 2017 both Anja Meissner and Martin Magnusson were recruited to WCMM Lund, as

https://www.wcmm.lu.se/article/successful-translational-research-between-two-researchers-wcmm-lund - 2025-03-09

Andreas Edsfeldt receives a translational award for studies on diabetes and the risk of cardiovascular diseases

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 22 September 2021 The Swedish Medical Society's Translational Prize 2021 is awarded to Andreas Edsfeldt, researcher and associate professor at the Department of Clinical Sciences, Lund University, and a doctor at the Heart Care Section, Skåne University Hospital Malmö. Andreas Edsfeldt is rewarded for his applica

https://www.wcmm.lu.se/article/andreas-edsfeldt-receives-translational-award-studies-diabetes-and-risk-cardiovascular-diseases - 2025-03-09

Kick-off for WCMM Research School 2021-2022!

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 1 October 2021 WCMM Research School is one of the most important pieces of regenerative medicine training we provide here as a centre. This year we will have have 18 students, ranging from 1st year PhD students to senior post-docs from different faculties, including LTH, Biology, Clinicians and the Faculty of Med

https://www.wcmm.lu.se/article/kick-wcmm-research-school-2021-2022 - 2025-03-09

WCMM Research School External Speaker Seminar

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 12 November 2021 We are delighted to host Dr. Alejo Rodriguez Fraticelli from IRB Barcelona. Since 2021, he heads the Lab of Quantitative Stem Cell Dynamics at IRB Barcelona where his  group focuses on understanding the mechanisms that regulate blood stem cell heterogeneity and how they play a role in homeostasis

https://www.wcmm.lu.se/article/wcmm-research-school-external-speaker-seminar - 2025-03-09

Asgard Therapeutics raises EUR 6M in Seed Financing to exploit direct in vivo reprogramming

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 12 November 2021 Filipe Pereira. Photo: Kennet Ruona Asgard Therapeutics AB, a private biotech company which originate from Lund University’s Cell Reprogramming and Immunity lab, led by the WCMM Fellow Professor Filipe Pereira, has announced the completion of a EUR 6 million seed financing round. The financing wa

https://www.wcmm.lu.se/article/asgard-therapeutics-raises-eur-6m-seed-financing-exploit-direct-vivo-reprogramming - 2025-03-09

Patient specific 3D-printed skull implants

By lisa [dot] karlsson [at] med [dot] lu [dot] se (Lisa Karlsson) - published 13 December 2021 As part of a larger study, a first successful operation using 3D printed cranioplasty implant has been done at Skåne university hospital. The Wallenberg Molecular Medicine Clinical Researcher Einar Heiberg is one of the clinicians behind the new method where imaging and image processing are used to devel

https://www.wcmm.lu.se/article/patient-specific-3d-printed-skull-implants - 2025-03-09

Does the food we eat have an impact on our brain?

Published 24 February 2022 The WCMM researcher Joao Duarte and his team strive to understand how a diet rich on fat and sugar impacts memory functions in relation to obesity and type 2 diabetes. Their new study on mice shows that although an unhealthy diet leads to memory impairment, the damage does not have to be permanent. The WCMM researcher Joao Duarte was recently in focus when Lund Universit

https://www.wcmm.lu.se/article/does-food-we-eat-have-impact-our-brain - 2025-03-09

‘My vision is that no patients should die waiting for an organ transplant’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 3 May 2022 Wallenberg Molecular Medicine Clinical Researcher - Sandra Lindstedt The focus of cardiothoracic surgeon Sandra Lindstedt and her research team is lung transplantation. “Today, we can only use 20 percent of the donor lungs. What if we could recondition and regain lung function of just a portion of thos

https://www.wcmm.lu.se/article/my-vision-no-patients-should-die-waiting-organ-transplant - 2025-03-09

‘I hope that I will be able to tell my patients that we have a curative therapy’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 3 May 2022 Wallenberg Molecular Medicine Clinical Researcher - Karin Tran Lundmark Paediatric cardiologist Karin Tran Lundmark treats patients with pulmonary hypertension, a condition that means high blood pressure in the lung. Karin Tran Lundmark’s research is focused on finding ways to treat what is causing the

https://www.wcmm.lu.se/article/i-hope-i-will-be-able-tell-my-patients-we-have-curative-therapy - 2025-03-09

‘By understanding more we can identify new therapies for complications due to type 2 diabetes’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 4 May 2022 Wallenberg Molecular Medicine Clinical Researcher - Andreas Edsfeldt Cardiologist Andreas Edsfeldt’s focus in research is to understand the underlying biology in type 2 diabetes associated with certain complications, such as myocardial infarction and stroke. “Cardiovascular complications are much more

https://www.wcmm.lu.se/article/understanding-more-we-can-identify-new-therapies-complications-due-type-2-diabetes - 2025-03-09

‘The children always ask: Why did I get this?’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 11 May 2022 Wallenberg Molecular Medicine Clinical Researcher - Robin Kahn Rheumatologist Robin Kahn’s focus in research is children with juvenile idiopathic arthritis. Together with his research team, he is trying to find the answers to two questions: why certain children get this condition – and how can it be c

https://www.wcmm.lu.se/article/children-always-ask-why-did-i-get - 2025-03-09

’I hope that my research will lead to more knowledge about bacteria in cystic fibrosis’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 18 May 2022 Wallenberg Molecular Medicine Clinical Researcher - Lisa Påhlman Lisa Påhlman, a specialist in infectious diseases, has a main research focus on airway infections in cystic fibrosis – a genetic disease that affects many organs of the body, perhaps most importantly the lungs. “If we knew more about the

https://www.wcmm.lu.se/article/i-hope-my-research-will-lead-more-knowledge-about-bacteria-cystic-fibrosis - 2025-03-09

‘Already now, we are producing patient-specific implants that shorten the surgical time’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 30 May 2022 Wallenberg Molecular Medicine Clinical Researcher - Einar Heiberg The focus of medical engineer Einar Heiberg’s research is on empowering physicians with patient-specific 3D models to help each patient. “The vision that I have is that for complex surgeries, the surgeons have already done the surgery m

https://www.wcmm.lu.se/article/already-now-we-are-producing-patient-specific-implants-shorten-surgical-time - 2025-03-09

‘We hope to find a neuroprotective treatment that can slow down the disease progression’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 1 June 2022 Wallenberg Molecular Medicine Clinical Researcher - Gesine Paul-Visse Neurologist Gesine Paul-Visse's research focus is on discovering, developing and implementing new therapies for neurological diseases such as Parkinson’s disease and stroke. “I am motivated every day by the need of the patients I me

https://www.wcmm.lu.se/article/we-hope-find-neuroprotective-treatment-can-slow-down-disease-progression - 2025-03-09

‘It's every researcher's dream to find new treatments for diseases’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 8 June 2022 Wallenberg Molecular Medicine Clinical Researcher - Martin Magnusson The focus of cardiologist Martin Magnusson’s research is epidemiological clinical heart failure as well as diabetes and cardiovascular studies. “We use large population-based and patient-based cohorts to investigate biomarkers and th

https://www.wcmm.lu.se/article/its-every-researchers-dream-find-new-treatments-diseases - 2025-03-09

’The need for better therapeutic options for brain cancers is very big’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 15 June 2022 Wallenberg Molecular Medicine Clinical Researcher - Anders Wittrup The focus of oncologist Anders Wittrup’s research is so called RNA therapeutics and how it can be developed into cancer therapies. “We have a special focus on brain cancers for which there today are very poor treatment options.” Ander

https://www.wcmm.lu.se/article/need-better-therapeutic-options-brain-cancers-very-big - 2025-03-09

‘I believe that validated PET-imaging biomarkers could transform the future clinical cancer care’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 22 June 2022 Wallenberg Molecular Medicine Clinical Researcher - Elin Trägårdh The focus of senior consultant Elin Trägårdh’s research is diagnostic nuclear medicine – in particular a modality called PET/CT. It is used mainly for evaluation of patients with cancer. Today, PET/CT is reviewed manually by doctors. ”

https://www.wcmm.lu.se/article/i-believe-validated-pet-imaging-biomarkers-could-transform-future-clinical-cancer-care - 2025-03-09

“I would like to come to a point where we cure even more children that are diagnosed with leukaemia”

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 29 June 2022 Wallenberg Molecular Medicine Clinical Researcher - Kees-Jan Pronk The focus of paediatric oncologist Kees-Jan Pronk’s research is to find out what happens with the blood system in children that develop leukaemia. The other focus of his research is to reduce side effects of leukaemia treatments. “We

https://www.wcmm.lu.se/article/i-would-come-point-where-we-cure-even-more-children-are-diagnosed-leukaemia - 2025-03-09